SUNNYVALE, Calif., April 18, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today clarification on two voluntary recalls that the company initiated on March 19, 2013.
In keeping with its commitment to patient safety and total quality management, Accuray has voluntarily implemented a recall of two separate components from its CyberKnife® product line: the Iris™ Variable Aperture Collimator and the RoboCouch® Patient Positioning System. The affected parts are manufactured by third-party suppliers and are being removed from the system because they failed to meet the company's specifications and standards for quality. The company has notified impacted customers, and field service personnel have been deployed to apply the corrections should they be necessary. These recalls exclude the CyberKnife® M6 Series ™ Series.
The first recall affects 176 units of the Iris Variable Aperture Collimator used in the CyberKnife System. Specifically, a defect was identified that could potentially result in a shift to the central axis of the radiation beam, posing a potential clinical impact to plans created using the smallest collimators. The second recall affects 16 units of the RoboCouch® Patient Positioning System used with the CyberKnife System. Specifically, the gear box responsible for patient motions may be defective. All defective gearboxes have been replaced. For both products, all affected sites have been notified and corrective actions are being taken.
"The recent FDA recall announcement comes roughly a month after Accuray took the necessary steps to voluntarily recall affected components. We are pleased to report that no known injuries have been reported to date as a result of these issues, and that we took the voluntary action to ensure that our product quality and outstanding safety record are maintained," said Joy Sacmar, vice president of regulatory affairs and quality assurance of Accuray. "Events such as these are not uncommon in our industry."
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV